Imperial College London

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1907-07-08

Employees: 5K

Market Cap: -

Website: http://www.imperial.ac.uk

Clinical Trials

The Effect of Protein-enriched Diet on Body Composition and Appetite

Not Applicable

Completed

Conditions: Obese
Non Alcoholic Fatty Liver Disease
Overweight
Metabolic Syndrome

Interventions: Dietary Supplement: High Protein, low calorie meal replacement

First Posted Date: 2012-07-06

Last Posted Date: 2022-04-28

Lead Sponsor: Imperial College London

Target Recruit Count: 39

Registration Number: NCT01634048

Locations: 🇬🇧
Imperial College London, London, United Kingdom

Radial Artery Versus Saphenous Vein Patency (RSVP) Trial - 10 Year Follow-up

Not Applicable

Withdrawn

Conditions: Coronary Artery Disease

Interventions: Procedure: Coronary artery bypass surgery using a long saphenous vein conduit
Procedure: Coronary artery bypass (CABG) surgery using a radial arterial conduit

First Posted Date: 2012-06-19

Last Posted Date: 2019-03-01

Lead Sponsor: Imperial College London

Registration Number: NCT01622387

Locations: 🇬🇧
Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom

Repeated Application of Gene Therapy in CF Patients

Phase 2

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: Placebo
Drug: pGM169/GL67A

First Posted Date: 2012-06-18

Last Posted Date: 2015-10-22

Lead Sponsor: Imperial College London

Target Recruit Count: 130

Registration Number: NCT01621867

Locations: 🇬🇧
Royal Hospital for Sick Children, Edinburgh, United Kingdom
🇬🇧
Western General Hospital, Edinburgh, United Kingdom
🇬🇧
Royal Brompton Hospital, London, United Kingdom

Multimedia Information and Pre-operative Anxiety

Not Applicable

Terminated

Conditions: Anxiety

Interventions: Other: video
Other: leaflet

First Posted Date: 2012-06-18

Last Posted Date: 2023-08-22

Lead Sponsor: Imperial College London

Target Recruit Count: 50

Registration Number: NCT01621828

Locations: 🇬🇧
Imperial College Healthcare NHS Trust Charing Cross Hospital, London, United Kingdom

NUC-1031 in Patients With Advanced Solid Tumours

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: NUC-1031

First Posted Date: 2012-06-18

Last Posted Date: 2024-03-20

Lead Sponsor: Imperial College London

Target Recruit Count: 68

Registration Number: NCT01621854

Locations: 🇬🇧
NIHR/Wellcome Trust Imperial CRF, London, Hammersmith, United Kingdom

[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer

Phase 1

Completed

Conditions: Ovarian Neoplasm

Interventions: Drug: Pazopanib and paclitaxel

First Posted Date: 2012-05-30

Last Posted Date: 2017-03-10

Lead Sponsor: Imperial College London

Target Recruit Count: 16

Registration Number: NCT01608009

Locations: 🇬🇧
Southend University Hospital NHS Foundation Trust, Southend, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Stem Cells in Rapidly Evolving Active Multiple Sclerosis

Phase 1

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Mesenchymal stem cells
Drug: Placebo

First Posted Date: 2012-05-25

Last Posted Date: 2019-08-09

Lead Sponsor: Imperial College London

Target Recruit Count: 21

Registration Number: NCT01606215

Locations: 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Yoga And Cardiovascular Health Trial

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Other: Yoga

First Posted Date: 2012-05-15

Last Posted Date: 2016-11-11

Lead Sponsor: Imperial College London

Target Recruit Count: 80

Registration Number: NCT01597960

Locations: 🇬🇧
International Centre for Circulatory Health, London, United Kingdom

The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects

Phase 1

Completed

Conditions: Idiopathic Pulmonary Arterial Hypertension

Interventions: Drug: (Pyr1)apelin-13
Drug: Saline

First Posted Date: 2012-05-02

Last Posted Date: 2019-04-16

Lead Sponsor: Imperial College London

Target Recruit Count: 12

Registration Number: NCT01590108

Locations: 🇬🇧
Hammersmith Hospital, Imperial College London, London, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Hereditary Haemorrhagic Telangiectasia Flight Safety Study

Completed

Conditions: Hereditary Haemorrhagic Telangiectasia

Interventions: Other: Aeroplane flight in the past- no active intervention for study
Other: Questionnaire

First Posted Date: 2012-05-02

Last Posted Date: 2024-11-11

Lead Sponsor: Imperial College London

Target Recruit Count: 156

Registration Number: NCT01590121

Locations: 🇬🇧
HammersmithHospital, Imperial College Healthcare NHS Trust, London, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy